Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conall Hayes

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Frontiers in Immunology|February 14, 2022
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint InhibitionNoel E Donlon, Maria Davern, Andrew D Sheppard, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2022
FLOT and CROSS chemotherapy regimens alter the frequency of CD27<sup>+</sup> and CD69<sup>+</sup> T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapyMaria Davern, Noel E Donlon, Andrew S Sheppard, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Frontiers in Immunology|February 14, 2022
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint InhibitionNoel E Donlon, Maria Davern, Andrew D Sheppard, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2022
FLOT and CROSS chemotherapy regimens alter the frequency of CD27<sup>+</sup> and CD69<sup>+</sup> T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapyMaria Davern, Noel E Donlon, Andrew S Sheppard, et al.
Pageof 2